Analysis Of Factors Influencing The Growth Of The Listed Medicine Company

At present, the enterprise growth has become a hotspot, different industry growth factors each are not identical. Pharmaceutical industry as an important part of national economy national health, medicine directly related to the healthy growth of the listed companies of the pharmaceutical industry to develop a great influence on the listed company growth, study medicine realistic meanings. So in this paper based on the existing literature, focus on analyzing pharmaceutical industry growth in financial factors in this analysis, and based on the development of medicine industry to put forward the corresponding proposal.This paper selects the shenzhen stock exchange 119 medicine in 2007 to 2009 listed company three years as a main financial indexes by using factor analysis regressors, receive financial aspects of the male factor to growth judging indexes, such as net profit growth, operating income growth, city net rate and tobin Q and a regression analysis.The drug industry growth factors is relatively complex, including not only the financial status and the enterprise’s management strategy, and managers including external environment change. This article through studies of each enterprise in pharmaceutical industry differences in financial management, thinks pharmaceutical enterprise after the short-term debt paying ability, capital operation ability, development of enterprise collaborators and asset scale had significant effects on the growth, thus concludes improve medicine effective ways of listed company growth, from a financial perspective for the medical industry growth factors provide empirical evidence.This paper is divided into six parts:The first part, introduction. Introduces the background and significance of this paper, aiming at the objective identified this research ideas and framework arrangement, analyzes the contribution and deficiencies. The second part, the literature review. Literature review paper from growth index selection part standard and growth evaluation system are introduced in this paper establish standard two predecessors’achievements at home and abroad, especially in the listed company growth factors on research. Lack of unity for growth evaluation indexes by understanding question, the paper classified influence factor analysis method of variable, refining and growing induces the typical growth factors index.The third part, theoretical basis. Theory and basic part first defines the concept "growth" this important business enterprise growth theory, and then from the perspective of the development of enterprise growth, secondly analyzes systematically the growth, thus this evaluation method for this paper empirical research and lay a theoretical basis.The fourth part, industry background. In contrast to introduce the five medical superpower status quo basis, the key industry analyzed and the pharmaceutical industry characteristics of the challenges and opportunities and the future development trend. This part of China’s pharmaceutical industry growth as the Angle of view, the pharmaceutical industry macro sort of system background and economic growth environment, micro theory analysis of the present stage of our country medicine enterprise growth of present and future.The fifth part, empirical research. This paper adopts factor method and regression method, comprehensive analyses factors affecting medical listed company growth, the paper believes that the listed company growth factors affecting medical operation ability not only includes the basic financial elements, as a high-tech company, its growth factors affecting development costs include also independent innovation ability and independent research and development ability, and these factors on the factors listed company growth impact pharmaceutical more direct and lasting.The sixth part, study concluded. On the base of case study, the paper puts forward pharmaceutical industry special background for pharmaceutical industry development in China, and puts forward ways suggested lowering costs and independent patent drugs is to promote the development of China’s pharmaceutical industry development reality way.The main contribution of this: This paper analyses the influence factors of pharmaceutical industry growth, and further expanded enterprise growth factors, and research for the medical industry growth factors of subsequent research to provide literature foundation and empirical evidence.This paper limitations:This study limitations of index system. Medicine listed company growth factors influencing factors include more, comprehensive and analysis, this paper has certain difficulty for financial basic indexes only researches and analysis, research conclusions exist a certain limitation.